These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5889339)

  • 1. [Investigation of pharmacologic agents with prolonged hypotensive action].
    Vinogradova EV; Grinev AN; Danusevich IK; Dzik MF; Dubovik BV; Zakharevskiĭ AS; Il'iuchenok TIu; Kost AN; Martinovich GI; Miklevich AV; Pil'tienko LF; Rachkovskaia IV; Reut NA; Talapin VI; Tamarina NZ; Terent'ev AP; Shadurskiĭ KS
    Vestn Akad Med Nauk SSSR; 1963; 18(1):69-86. PubMed ID: 5889339
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new hypotensive agent with central action].
    Fritel D
    Therapeutique; 1970 Nov; 46(9):893-5. PubMed ID: 5486137
    [No Abstract]   [Full Text] [Related]  

  • 3. Myocardial effects of indoramin hydrochloride, a new hypotensive agent.
    Coltart DJ; Meldrum SJ; Royds RB
    Br J Pharmacol; 1971 Aug; 42(4):664P-665P. PubMed ID: 5116056
    [No Abstract]   [Full Text] [Related]  

  • 4. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
    Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T
    Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [2-Methylindoles substituted in the 1st, 3d and 5th positions and the diffuse neuroendocrine APUD system].
    Shadurskiĭ KS; Il'iuchenok TIu; Shadurskaia SK
    Farmakol Toksikol; 1983; 46(2):115-20. PubMed ID: 6133776
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypotensive effect of oxatriazolium-5-olate derivative].
    Artem'eva MM; Postnikov AB; Akinfrieva OV; Daliger IL; Shevelev SA; Medvedev OS; Medvedeva NA
    Eksp Klin Farmakol; 2008; 71(5):25-7. PubMed ID: 19093367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of a new antihypertensive agent in several species.
    Salvati P; Caravaggi AM; Lamberti E; Monteggia M; Bianchi G
    Arzneimittelforschung; 1983; 33(8):1098-106. PubMed ID: 6685486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study on the hypotensive action and mechanism of berbamine hydrochloride (author's transl)].
    Zhou ZD; Han CH; Wang P
    Yao Xue Xue Bao; 1980 Apr; 15(4):248-50. PubMed ID: 7457144
    [No Abstract]   [Full Text] [Related]  

  • 9. Rhomotoxin pharmacologic action in lowering blood pressure and slowing heart rate.
    Mao HY; Li CY; Cui JJ; Feng YB; Hu WS; Guo QG; Jiang MX
    Chin Med J (Engl); 1982 May; 95(5):311-8. PubMed ID: 6814841
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypotensive effects of 9-o-ethyl lycorenine-HCl (author's transl)].
    Wang H; Gu TH; Gu DG; Wu SW; Cai MD; Qiu XS; Zhao GS; Shen GQ
    Zhongguo Yao Li Xue Bao; 1980 Sep; 1(1):30-4. PubMed ID: 6461172
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism of hypotensive action of scoparone.
    Sharma ML
    Indian J Med Res; 1988 Apr; 87():387-94. PubMed ID: 3169895
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypotensive activity of beta-heptamethylenimino-ethylaminoguanidine sulfate.
    Botton I; Kinnard WJ; Buckley JP
    J Pharmacol Exp Ther; 1966 May; 152(2):243-50. PubMed ID: 5944368
    [No Abstract]   [Full Text] [Related]  

  • 13. [A decrease in arterial pressure by using organic nitrates].
    Kleist P; Bussmann WD
    Ter Arkh; 1993; 65(2):90-3. PubMed ID: 9133023
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of the ganglionic blocking agent pyrilene together with other hypotensive agents].
    Tikhonenko VM; Kazak LI
    Vrach Delo; 1973 Mar; 3():19-21. PubMed ID: 4733020
    [No Abstract]   [Full Text] [Related]  

  • 15. The hypotensive effect of dauricine and its mechanism of action.
    Chen SH; Hu CJ
    Acta Acad Med Wuhan; 1983; 3(2):125-7. PubMed ID: 6866387
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the hypotensive action of preparations from the roots of Petasites officinalis (L.) Moench. fam. Compositae].
    Efimova FV; Petrov MI
    Farmakol Toksikol; 1965; 28(3):292-4. PubMed ID: 5869643
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mechanism of the hypotensive action of inkrepan].
    Surovikina MS; Andreev SV; Kobkova ID
    Patol Fiziol Eksp Ter; 1984; (5):40-3. PubMed ID: 6393014
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dipeptidyl carboxypeptidase inhibitors--a new class of antihypertensive agents].
    Shvarts GIa
    Farmakol Toksikol; 1984; 47(2):105-15. PubMed ID: 6370719
    [No Abstract]   [Full Text] [Related]  

  • 19. [The rationale for drug combinations in the therapy of arterial hypertension].
    Salvetti A; Virdis A; Di Venanzio L
    Ann Ital Med Int; 1993 Oct; 8 Suppl():107S-110S. PubMed ID: 8117517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacologic action of Ag 307 on various experimental physiopathologic syndromes (ammonium poisoning, inflammatory conditions, chronic hypertension)].
    Laborit H; Weber B; Fukunaga A
    Agressologie; 1968; 9(6):683-92. PubMed ID: 5729130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.